ArticleItalian journal of pediatrics2025

The utilization of the multimodal immunotherapy for the opsoclonus-myoclonus syndrome can reduce relapses and permanent neurological sequelae.

Fang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.